These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19394183)

  • 21. Whole-heart coronary magnetic resonance angiography with MS-325 (Gadofosveset).
    Kelle S; Thouet T; Tangcharoen T; Nassenstein K; Chiribiri A; Paetsch I; Schnackenburg B; Barkhausen J; Fleck E; Nagel E
    Med Sci Monit; 2007 Nov; 13(11):CR469-474. PubMed ID: 17968293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent.
    Spuentrup E; Katoh M; Buecker A; Fausten B; Wiethoff AJ; Wildberger JE; Haage P; Parsons EC; Botnar RM; Graham PB; Vettelschoss M; Günther RW
    Invest Radiol; 2007 Aug; 42(8):586-95. PubMed ID: 17620942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.
    Spuentrup E; Ruhl KM; Botnar RM; Wiethoff AJ; Buhl A; Jacques V; Greenfield MT; Krombach GA; Günther RW; Vangel MG; Caravan P
    Circulation; 2009 Apr; 119(13):1768-75. PubMed ID: 19307474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium--an interrater reliability study.
    Pfeil A; Betge S; Poehlmann G; Boettcher J; Drescher R; Malich A; Wolf G; Mentzel HJ; Hansch A
    Eur J Radiol; 2012 Mar; 81(3):547-52. PubMed ID: 21349675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent.
    Huang SY; Kim CY; Miller MJ; Gupta RT; Lessne ML; Horvath JJ; Boll DT; Evans PD; Befera NT; Krishnan P; Chan JL; Merkle EM
    AJR Am J Roentgenol; 2013 Jul; 201(1):208-14. PubMed ID: 23789677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral MRA with k-space segmentation and blood-pool contrast agent.
    Kinner S; Zenge MO; Heilmaier C; de Greiff A; Vogt FM; Ladd ME; Barkhausen J; Quick HH
    Acad Radiol; 2011 Jan; 18(1):113-9. PubMed ID: 20947388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravascular hematocrit layering in equilibrium phase contrast-enhanced MR angiography of the peripheral vasculature.
    Wang MS; Haynor DR; Wilson GJ; Maki JH
    J Magn Reson Imaging; 2006 Dec; 24(6):1393-400. PubMed ID: 17096397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadofosveset-enhanced magnetic resonance angiography of the thoracic vasculature in the equilibrium phase: feasibility and impact of dose.
    Kim CY; Heye T; Bashir MR; Gebhard TA; Merkle EM
    J Comput Assist Tomogr; 2013; 37(5):732-6. PubMed ID: 24045249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noncontrast 3D steady state free precession magnetic resonance angiography of the thoracic central veins using nonselective radiofrequency excitation over a large field of view: initial experience.
    Tomasian A; Lohan DG; Laub G; Singhal A; Finn JP; Krishnam MS
    Invest Radiol; 2008 May; 43(5):306-13. PubMed ID: 18424951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis of renal artery stenosis with magnetic resonance angiography and stenosis quantification].
    Marchand B; Hernandez-Hoyos M; Orkisz M; Douek P
    J Mal Vasc; 2000 Dec; 25(5):312-320. PubMed ID: 11148391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium.
    Naehle CP; Müller A; Willinek WA; Meyer C; Hestermann T; Gieseke J; Schild H; Thomas D
    J Magn Reson Imaging; 2009 Oct; 30(4):809-16. PubMed ID: 19787726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadofosveset-enhanced MR imaging for the preoperative evaluation of potential living kidney donors: correlation with intraoperative findings.
    Kuhlemann J; Blondin D; Grotemeyer D; Zgoura P; Reichelt D; Heinen W; Scherer A; Lanzman RS
    Rofo; 2010 Nov; 182(11):1001-9. PubMed ID: 20922646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents.
    Maki JH; Wang M; Wilson GJ; Shutske MG; Leiner T
    J Magn Reson Imaging; 2009 Nov; 30(5):1085-92. PubMed ID: 19856442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
    Klessen C; Hein PA; Huppertz A; Voth M; Wagner M; Elgeti T; Kroll H; Hamm B; Taupitz M; Asbach P
    Invest Radiol; 2007 Sep; 42(9):659-64. PubMed ID: 17700282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease.
    McGregor R; Vymazal J; Martinez-Lopez M; Neuwirth J; Salgado P; Beregi JP; Peduto A; de la Pena-Almaguer E; Slater GJ; Shamsi K; Parsons EC
    Eur J Radiol; 2008 Feb; 65(2):316-25. PubMed ID: 17499952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroradiologic applications of dynamic MR angiography at 3 T.
    Parmar H; Ivancevic MK; Dudek N; Gandhi D; Geerts L; Hoogeveen R; Mukherji SK; Chenevert TL
    Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):63-75. PubMed ID: 19364600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New experimental model of sinus and cortical vein thrombosis in pigs for MR imaging studies.
    Stracke CP; Spuentrup E; Katoh M; Günther RW; Spangenberg P
    Neuroradiology; 2006 Oct; 48(10):721-9. PubMed ID: 16967263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Display of dural sinuses with time-resolved, contrast-enhanced three-dimensional MR venography.
    Meckel S; Glücker TM; Kretzschmar M; Scheffler K; Radü EW; Wetzel SG
    Cerebrovasc Dis; 2008; 25(3):217-24. PubMed ID: 18216463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-resolved contrast-enhanced MRA (TWIST) with gadofosveset trisodium in the classification of soft-tissue vascular anomalies in the head and neck in children following updated 2014 ISSVA classification: first report on systematic evaluation of MRI and TWIST in a cohort of 47 children.
    Higgins LJ; Koshy J; Mitchell SE; Weiss CR; Carson KA; Huisman TA; Tekes A
    Clin Radiol; 2016 Jan; 71(1):32-9. PubMed ID: 26474946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dixon-based fat-free MR-angiography compared to first pass and steady-state high-resolution MR-angiography using a blood pool contrast agent.
    Homsi R; Gieseke J; Kukuk GM; Träber F; Willinek WA; Schild HH; Hadizadeh DR
    Magn Reson Imaging; 2015 Nov; 33(9):1035-1042. PubMed ID: 26220860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.